Postmenopausal women on tirzepatide show lower weight loss than those typically seen with the obesity drug, but weight loss ...

In patients with obesity, tirzepatide improved cardiometabolic parameters and risk for cardiovascular disease, but the ...

Where, How, and Why You Exercise Affects Mental Health: StudyPublished in Medicine and Science in Sports and Exercise, a recent study from the ...

Anti-obesity medications can significantly raise testosterone levels and improve health outcomes for men with obesity or type ...

Popular anti-obesity medications continue to be effective for weight loss even when availability and access is interrupted, ...

Combining ASC47 with semaglutide, the new therapy aims to reshape obesity treatment with targeted, once-monthly injections.

New research finds that men taking a GLP-1 for their obesity or type 2 diabetes often experience a rise in testosterone ...

People who take GLP-1 drugs like Ozempic can lose weight even if they face disruptions in accessing the medications, which ...

Popular anti-obesity medications continue to be effective for weight loss even when availability and access is interrupted, ...

Overview of Obesity Treatment MarketThe global Obesity Treatment Market is valued at USD 22.2 Billion in 2024 and is projected to reach a value of USD 194.1 Billion by 2035 at a CAGR (Compound Annual ...

Explore the growing GLP-1 agonists market, driven by rising diabetes and obesity rates. Discover advancements in therapies like Tirzepatide and GZR18 ...

A phenotype-based profiling test can help predict whether a patient might respond better to one antiobesity medicine or ...